The document covers materials such as Influenza A (H1N1) vaccines safety and effectiveness, the immunogenicity, benefit-risk evaluation, vaccine manufacturers, the vaccines authorised, research, clinical and public health centres, components of strategies in monitoring the benefit-risk A/H1N1 vaccines, and the funding mechanisms in relation to the overall benefit-risk assesment.
Archives for Swine Flu
H1N1 Article: Clinical Management Protocol for Swine Influenza
Herein is an article dicussed Clinical Management Protocol for H1N1 Influenza A (Swine Flu) Virus. There are section discussed : clinical management protocol, Guidelines on Infection Control Measures, operating procedures for infection control practices.
Swine Flu Antiviral Medication for High-Risk Group
Antiviral treatment and chemoprophylaxis efforts of influenza A (H1N1)-Swine Flu are recommended primarily at persons who are hospitalizad or at high risk for influenza complications. And the following article will give description about Swine Flu Antiviral Medication for these High-Risk Groups.
Clinical Complications of Influenza Virus Infection
Prevention and treatment strategies against risks of influenza complications are needed to improve outcomes for those at highest risk of influenza virus emerge. Herein we provide you with informations about the clinical complications of viral influenza (influenza A-H1N1 and H3N2, influenza B)
